University of Texas at Austin

news

Antibodies cover entirety of SARS-CoV-2 Spike protein, study shows

5 May 2021 | By Victoria Rees (Drug Target Review)

Researchers have found that over 80 percent of antibodies target sections of the SARS-CoV-2 Spike protein other than the RBD.

news

Hepatitis C drugs shown to boost remdesivir’s activity against SARS-CoV-2

28 April 2021 | By Victoria Rees (Drug Target Review)

Four hepatitis C drugs have demonstrated promise as boosters to increase the efficacy of remdesivir against SARS-CoV-2 by as much as tenfold.

news

SARS-CoV-2 model shows Spike protein co-operation

1 March 2021 | By Victoria Rees (Drug Target Review)

A new coarse-grained model of the complete SARS-CoV-2 virion has revealed potential new ways to combat the coronavirus.

news

Antibodies developed from llama show promise in fighting COVID-19

30 April 2020 | By Victoria Rees (Drug Target Review)

Engineering antibodies found in a llama, researchers have developed a potential COVID-19 therapy which they say can neutralise SARS-CoV-2.

news

DNA barcodes that reliably work: A game-changer for biomedical research

31 December 2018 | By Drug Target Review

A new method for correcting the errors that creep into DNA barcodes has paved the way for more ambitious medical research...